Findings from the Annual Meeting of the American Society of Clinical Oncology
Here are some findings from the Annual Meeting of the American
Society of Clinical Oncology, held in May in Orlando, Florida:
- There’s some indication that a low-fat diet—comprising
15% of daily calories—may help increase the time between recurrence of breast
cancer, as indicated in a study in post-menopausal women with primary breast
cancer. More research needs to be done on this, but there has been evidence
previously that overweight women have higher rates of breast cancer and poorer
outcomes after treatment.
- Childhood cancers now have a cure rate of about 78
percent. This is wonderful news, but it’s important for these survivors to
know that the cancer itself or the necessary toxic effects of treatment can
have long-lasting effects. For example, the cancer survivors were 4.2 times
more likely to have a chronic condition than their siblings were. Survivors
who had had both chemotherapy and radiation had a higher rate of chronic
- Herceptin, a new-generation breast cancer drug, has
already been known to prolong survival in women with advanced breast cancer.
But clinical trials have shown that Herceptin also has a strong benefit for
women in the early stages of breast cancer. (For more about this, read the
article in our February Cancer E-magazine, “Recent Findings about Breast
Annual Meeting of
the American Society of Clinical Oncology.